PUBLICATIONS - PEEERED VIEWED:

1. Kilminster, S.G. and Jones, D.M. (1986).Perceived control and the cold pressor test. Stress Medicine. 2, 73-77.

2. Kilminster, S.G, Lewis, M., Jones, D.M. and Henderson (1987). Measurement of Psychological side effects of acebutolol and atenolol in hypertensive patients. Xth Congress of Pharmacology. Sydney.

3. Kilminster, S.G., Lewis, M., Jones, D.M. (1988). Anxiolytic effects of acebutolol and atenolol in healthy volunteers with induced anxiety. Psychopharmacology. 95, 245-249.

4. Kilminster, S.G. (1988) Structure and redundancy in Higher School Certificate and the Australian Scholastic Aptitude Test (ASAT): A factor analytic study. AustralianNationalUniversity. SPPS Report 32, 1-25.

5. Kilminster, S.G. (1988) Improvement of prediction of first year performance in one faculty at the ANU: A variance partitioning approach. SPPS Report 30, 1-26.

6. Kilminster, S.G., Lewis, M., Jones, D.M. and Henderson (1989). Effects of acebutolol and atenolol on mood and cognition when given to healthy volunteers or to hypertensive patients . Journal of Drug Development.

7. Kilminster, S.G. (1989) The psychological effects of beta-blockers:methodological critique and literature review of the previous 20 years. Journal of Drug Development. 2 (3).

8. Kilminster, S.G. and Miller, A. (1989) The SPPS review. 1975-1988. Australian Universities Review, 32 (1), 17-21.

9. Kilminster, S.G. (1991). A longitudinal study of cognitive performance in the elderly:cross sectional versus longitudinal data. In Molecules Methods and Measurement. Eds I Hindmarch & Wilcox. John Wiley and Sons.

10. Kilminster, S.G.,Moon, C.A. and Hindmarch, I. (1992). Cognition and Mood in elderly depressed patients treated with ether fluoxetine or amitriptyline. British Journal of Clinical Pharmacology, 33(2), pp 246-246.

11. Kilminster, S.G. and Sutton, A., Concas, V., Stalla Boudillon, (1992). Zacopride (Selective 5HT-3 Receptor agonist) v lorazepam v placebo psychopharmacodynamic profiles in healthy volunteers. Proc. British Pharmacological Society.

12. Kilminster .S.G.(1989) A human model for determining anxiolysis in non patient populations. CNS Drug Development. Post House Conference Centre. Guildford.

13. Kilminster, S.G. (1990) The use of the Sternberg Memory Paradigm in psychopharmacodynamic profiling. Conference on Applied Psychopharmacology. Institute of Psychiatry. University of London.

14. Kilminster, S.G. (1994) . The Kilminster Anxiety Induction Paradigm (KAIP) in use at Guildford Clinical Pharmacology Unit. at the RoyalSurreyCountyHospital. Postgraduate Medical Conference. Ditto Psychotropic Pharmaceuticals Conference.SMIOct 9th 1997

15. Sutton, A &Kilminster, S.G. (1994) Octylonium Bromide actions on gastric emptying by epigastric impedance, orocaecal transit times (measured by the lactulose breath hydrogen method ) and by radio opaque pellets. Sept. Proc Brit Pharmacol Soc.

16. Kilminster, S.G.,.Sutton,JA, and Mould,G. (1994) Anxiety Paradigm (KAIP) in healthy volunteers.(Guildford versus Cardiff Studies). Dec. p317. Proc. Brit. Pharmacol. Soc.

17. Sutton, A &Kilminster, S.G. & Mould G.P (1997) The clinical pharmacology of single doses of octilonium bromide in healthy volunteer. Eur J Clin Pharmacol. 52: 365-369

18. Kilminster, S.G., Sutton, A ., Dunstan, D., & Mould, G.M (1997). A new model of thresholds to Laser induced pain in volunteers differentiates between onset times of analgesia from effervescent and capsule formulations of the same analgesic combination. Eur J Clin Res;9 283-291

19. Rotmensch HH, Mould GP, Sutton,JA Kilminster SG, Moller C & Pero RW. (1997) Comparative central nervous system effects & pharmacokinetics of neu-metoclopramide 7 metoclopramide in healthy volunteers.Journal of Clinical Pharmacology. 37(3) 222-228.

20. Harrison. RF, Magill, P, Blackie S and Kilminster SG (1997). Endometrial safety of a new formulation of 17-b oestradiol and low-dose micronised medroxyprogesterone acetate. British J Clinical Research. 8:15-22.

21. Treasure, T, Kilminster SG, Mcmillan T, Wiley D & Holt D (1998). Improving brain protection during cardiopulmonary Bypass:S100 protein release and change in neuropsychological performance. Heart.Vol 79 Supp. 1, 99.

22. Harrison. RF, Magill, P, and Kilminster SG (1998).Impact of new formulation of low-dose micronised medroxyprogesterone acetate and 17-b oestradiol on the lipid profiles in menopausal women.. Clinical Drug Investigation. 16(2) 93-99.

23. Starkey BJ, &Kilminster SG, (1998), A high performance liquid chromatography method for salivary paracetamol and its application in a clinical trial. Proc Nat Assn. Clin Biochem.

24. Kilminster, S.G. et al .(1998) The prevention of post-menopausal bone loss with a new formulation of low dose micronised medroxyprogesterone acetate and 17-ß oestradiol.. J Clin Research. 259-267.

25. Kilminster,S.G. (2001). Manual of the Short pain inventory; measuring the whole pain experience. Published by Lawrencian Clinical Ltd. Selsey. UK.

26. Kilminster, S.G. Treasure T, McMillan T. Holt D .(1999) Neuropsychological change and S100b protein release in 130 unselected patients undergoing cardiac surgery. Stroke.September 1869-1874.

27. Kilminster, S,G& Mould.G.(1999). Comparison of diclofenac spray and gel on knee joints of patients with osteoarthritic pain. . Clin Drug Invest.. November18(5) 345-354

28. Kilminster, S.G. J (1999). New methods of measuring first and second pain. August Int J Pharm Medicine,13. 206-207

29. Kilminster, S.G. et al (2000). Survey of pain in two medical and dental clinics, with non patient controls using the Short Pain Inventory. Int J Pharm Medicine 2000.June. 14:137-147

30. Sutton. A, Gillin, W, Grattan, T, Clarke D, Kilminster S.G. A new laser pain threshold model detects a faster onset of action from a liquid formulation of 1g paracetamol than the equivalant tablet formulation. (2002) Br J Clin Pharmacol, 53, 43-47.

31. Puranik S, Fozard, J. Kilminster, S.G. A randomised single blind study to evaluate the effects of Action Potential Simulator Therapy compared with placebo in patients with chronic back pain. (2002). Pain Clinic. 14(1) 69-73

32. Kilminster,S.G. (2002). Comparison of the internal reliability and validity of the McGill Pain Questionnaire and Short Pain Inventory. Int J Pharm Med. March, 2002, 16:87-95

33. Kilminster, S.G. (2002) Simplified Power calculations for Clinical Investigators A 350 page book with examples and a new statistical test based upon the coefficient of variation.

34. Dowson A. &Kilminster S.G.Tryptan medications to treat acute migraine. Lancet 2002 359: 1151-1152.

35. Kilminster,S.G. Dowson A. & Bundy M. (2003). The Headache Impact Test & the Short Pain Inventory; Int J Pharm Med. March, 17(1):23-32.

36. Kilminster,S.G. Measuring Stress and Migraine. (2003) (Psychiatry). National Association for Primary Care Review. 222-223.

37. Kilminster, S.G Dowson A and Ellender D. (2003). Clinical investigation of medicinal products for the treatment of migraine. Society of Pharmaceutical Medicine. Int J Pharm Med. November, Volume 17, 3-4. 113-115

38. Kilminster,S.G Dowson A and Ellender D. (2004). Notes for guidance on clinical investigation of medicinal products for the treatment of migraine. Society of Pharmaceutical Medicine. Int J Pharm Med. November, Volume 18, Number 6.

39. Dowson AJ, Kilminster SG, Salt R, Clark M, Bundy MJ. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: A general practice study. Headache 2005;45:274–82.

40. Dowson AJ, Tepper SJ, Baos V Kilminster SG et al. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Curr Med Res Opin 2004;20:1125–35.

41. Dowson AJ, Salt R, Kilminster S. The outcome of headache management following nurse intervention: assessment in clinical practice using the Migraine Disability Assessment (MIDAS) Questionnaire. Headache Care 2004;1:177–81.

42. Dowson AJ , D Amico D, Tepper SJ, Kilminster SG.Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Neurol Sci 2004;24 (Suppl 3):s276–8.

43. Dowson AJ , Tepper SJ, Baos V, D’Amico D, Baudet F, Kilminster S. The Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire: a new assessment tool to identify patients who require a change in their current acute migraine treatment. Cephalalgia 2004;24:1093.

44. Dowson AJ , Tepper SJ, Baos , Kilminster SG. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Headache Care 2005;2:5–10.

45. Dowson AJ, Kilminster SG, Peters M, Lipiscome. Understanding the evidence: evaluating the efficacy of migraine medications in clinical practice. Headache Care 2005;2:133–43.

46. Dowson AJ, Turner A, Kilminster S et al. Development and validation of the headache Diagnostic Screening Questionnaire (DSQ): a new questionnaire for the differential diagnosis of headache for use in primary care. Headache Care 2005;2:111–18.

47. Tepper SJ, Baos V, Dowson AJ . Kilminster SG . The Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire: further investigation of study methodology and results. Headache Care 2005;2:27–31.

48. S Kilminster.1 AJ Dowson,2 SJ Tepper,3 V Baos,4 F Baudet,5 D D’Amico6 . Reliability, validity and clinical utility of the Migraine-ACT questionnaire. Headache. 2006; 46(4):553-562.

49. R. S. Bridger, S. Kilminster and G. Slaven. Occupational Medicine.Occupational stress and strain in theNaval service: 1999 and 2004. Occupational Medicine Volume 2 2006.

50. Andrew D; Bundy M, Salt, R &Kilminster S.G. Patient Preference for Triptan Formulations: A Prospective Study with Zolmitriptan. Headache, 2007. 1144-1151.

51. Dowson, A Kilminster S.Gand Salt R Clinical Profile of Botulinum Toxin A in Patients with Chronic Headaches and Cervical Dystonia. A Prospective, Open-Label, Longitudinal Study Conducted in a Naturalistic Clinical Practice Setting. Drugs R D 2008; 9 (3): 147-158.

52. Dowson A, Bundy, M and Kilminster S.G. Assessing Patients with Episodic Tension-TypeHeadache, Migraine or Chronic Daily Headache. Using the Short Pain Inventory. A Within-Group, Comparative Study to Assess Ability to Cope withHeadache, Emotional Function and Healthcare Utilization. Pharm Med 2008; 22 (3): 165-174

53. Brims, FJH; Kilminster, S; Thomas, LM; (2009) Resuscitation decisions among hospital physicians and intensivists. Clinical Medicine, 9 (1) 16 - 20.

54. Bridger RS Brasher K Dew A Kilminster S. 2008. Occupational stress and strain in the Naval Service 2007. Occupational Medicine, 2008. 58:534-539.

55. Kate S. Brasher, Angela B.C. Dew, Shaun G. Kilminster& Robert S. Bridger (2010). Stress in submariners: The impact of isolated and confined work on psychological wellbeing. Ergonomics. 53, 305-313.

56. Bridger RS Brasher K, Dew Kilminster S Job Stressors in Naval Personnel Serving on Ships and in Personnel Serving Ashore over a Twelve Month Period. Applied Ergonomics. 2011 Jul;42(5):710-8

57. Bridger RS Brasher K, Dew A Sparshott K Kilminster S. Job strain related to cognitive failure in Naval personnel. Ergonomics, Vol.5, no6, June, 2010, 739-747.

58. R. S. Bridger,S. Kilminster; G. Slaven. (2007). Occupational stress and strain in the naval service: 1999 and 2004. Occupational Medicine, 57:92-97.

59. Bridger RS Brasher K, Dew, K Munnoch and Kilminster S. Chronic and Acute Strain in Naval Personnel. 2009: Occupational Medicine. 59, 454-458.

60. S. Kilminster, S. Müller, M. Menon, J. V. Joseph, D. J. Ralph, and H. R. H. Patel, Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. British Journal of Urology International. 2012 vol. 110, no. 3, 422–426.

Plus 14 years of various military reports on psychiatry, psychometrics audiology, clinical audit etc: Restricted.

Press & Media Reports:

• New Scientist. 2003. Blood Test tells how much it hurts. Neurolgy Fontiers. 13 September: p24.

• Times Higher Education: www.timeshighereducation.co.uk/news/new-blood-test.../183958.article

• The Future Dr. Karlsbjerg: Wednesday, September 17, 2003. A potential revolution in pain research:Pain researcher ShaunKilminster has discovered a set of three neurotransmitters. www.karlsbjerg.net/blog/2003/09/17.html

• Spitting Image: Blood Test Tells How Much It Hurts. If this is for real, it's a Nobel Prize winner. Posted by Cieciel at September 15, 2003. www.consumptive.org/spittingimage/archives/003335.html

• Veterinary Sciences Tomorrow:: an online current awareness Inventor ShaunKilminster claims his test has already been shown to work in headache sufferers. It is certainly...www.vetscite.org/cgi-bin/pw.exe/Issue4/news/001405.htm

• EUROPA - Research - Headlines - New blood test answers painful To have an objective value is the scientific gold standard,” the test’s inventor ShaunKilminster, a pain researcher and external consultant at the RSCH.europa.eu.int/comm/research/headlines/ news/article_03_10_01_en.html

• Agrilari belirleyen kan testi gelistirildi Guildford’daki Kraliyet Hastanesi’nde görevli bilim adami ShaunKilminster, hekimlerin test yardimiyla kendinde olmayan hastalarin ve henüz. www.ntvmsnbc.com/news/233426.asp

• Anatolya.Net Guildford'daki Kraliyet Hastanesi'nde görevli bilim adami ShaunKilminster, test sayesinde hastanin agrisinin olup olmadigi ve agrinin siddetinin .www.anatolya.net/ haber_Detay.asp?section=7&sid=iJs1Oi9LFJqtRD

• Onet.pl - Wiadomosci - Wrazliwosc na ból ma sie we krwi Choc wielu specjalistów watpi, czy taki test jest w ogóle mozliwy, jego wynalazca - ShaunKilminster, jest pelen optymizmu - na razie wypróbowal. info.onet.pl/797889,16,item.html

• wissenschaft.de - News Der Test erkenne unabhängig von der Ursache, ob und in welchem Maße ein Patient Schmerzen habe. Das behauptet zumindest sein Entwickler ShaunKilminster. www.wissenschaft.de/wissen/news/228299

• Blood test to measure pain - smh.com.au New Scientist magazine reports that pain researcher ShaunKilminster has successfully used the test on migraine sufferers. www.smh.com.au/articles/2003/09/12/1063341761008.html

• Livio's Radio Weblog Dice infatti il New Scientist che il medico inglese ShaunKilminster ha trovato un modo oggettivo per la misura del dolore. livio.blogs.it/

• Planet - Bloedtest meet pijnniveauShaunKilminster, de uitvinder van de test, vertelt het tijdschrift New Scientist dat zijn test gebaseerd is op de hoeveelheid neurotransmitters. www.planet.nl/planet/show/id=75098/ contentid=404887/sc=99bc04

• Ansa Mednews - Sanihelp L'ha realizzato ShaunKilminsterdelRoyalSurreyCountyHos... Continua GB: GIOCO SU CELLULARE COMBATTE VOGLIA DI FUMARE, 12 SET. www.sanihelp.it/tools/ansanews/

• Biological Psychology Links But inventor ShaunKilminster claims his test has already been shown to work in headache sufferers. © Copyright Reed Business Information Ltd.www.biopsychology.com/

• Leipziger Bücherlei: Brosamen Weblog 2003/4 - Entwickelt hat den Test der britische Schmerzforscher ShaunKilminster vom königlichen Krankenhaus in Guildford. Ärzte wären.www.bibliomaniac.de/log/brosamen/

• SETsquared : News : This Week A simple blood test could be the first objective measure of how much pain someone is experiencing, according to its inventor ShaunKilminster, a pain ...www.setsquared.co.uk/news/this_week.asp

• Ansa Mednews - Sanihelp -L'ha realizzato ShaunKilminster del Royal Surrey County Hospital di Guildford, in Gran Bretagna, il quale spiega che il test ( ancora da validare su larg www.sanihelp.it/tools/ansanews/scheda.php?ID=6451

• Bluttest stellt Schmerzen fest - Der Test erkenne unabhängig von der Ursache, ob und in welchem Maße ein Patient Schmerzen habe, sagt sein Entwickler ShaunKilminster. www.abendblatt.de/daten/2003/09/11/206581.html

• New, simple blood test to determine pain. But inventor ShaunKilminster told the magazine his test has already been shown to work in headache sufferers. www.softcom.net/webnews/wed/cs/ Ubritain-pain.RSDJ_DSC.html

• MEDLOG: EXPOUNDING THE REAZLES FOR SNEEZLES AND WHEEZLES Dr ShaunKilminster's technique determines the relative amounts of three neurotransmitters in the blood.www.mahim.net/medlog/

• Zafer Ecza belirtildi. Guildford’daki Kraliyet Hastanesi’nde görevli bilim adami ShaunKilminster, hekimlerin test yardimiyla kendiDevami. www.zaferecza.com/

• Letters From Exile: whether such a test is possible. But inventor ShaunKilminster claims his test has already been shown to work in headache sufferers. hutchison.org/allen/

• Radikal-online / Yasam / Bebekte agri ölçülebilecek Britanya Guildford'daki Kraliyet Hastanesi'nde görevli bilim adami ShaunKilminster, gelistirdigi testle üç nörotransmitterin (sinirler arasi bilgi) www.radikal.com.tr/veriler/2003/09/12/haber_88383.php

• Newsletter For COPD-Support Programs Test is possible. But inventor ShaunKilminster claims his test has already been shown to work in headache sufferers. copd-support.org/news.html

• del 17 settembre 2003 - L'ha realizzato ShaunKilminster del Royal Surrey County Hospital di Guildford, in Gran Bretagna, il quale spiega che il test (ancora da validare su larga scala taranto.fimmg.org/news/settembre2003/ mininewsdel17.9.htm

• Galileo - Giornale di scienza e problemi globali La scoperta viene da ShaunKilminster, specialista del dolore e consulente esterna del Royal Surrey County Hospital di Guildford (Regno Unito) e potrebbe. www.galileonet.it/news/news.html

 

Take the headache test

Login if you've already purchased

See the test demo